AMST vs EW · rev $110.5K vs P/E 47, rev $1.39B
Amesite Operating Co (AMST) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Amesite Operating Co (AMST) is a software - application company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AMST revenue for 2025-06-30 was $110.5K. Net income was -$3.6M. Revenue was down 33.8% from 2024-06-30 to 2025-06-30. AMST currently screens at market cap $7.9M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AMST currently screens at market cap $7.9M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AMST and EW stock pages for the full models.
Not investment advice.